US20020022056A1
(en)
|
1997-02-14 |
2002-02-21 |
Burkhard Schlutermann |
Oxacarbazepine film-coated tablets
|
MXPA04011801A
(es)
*
|
2002-05-31 |
2005-09-12 |
Desitin Arzneimittel Gmbh |
Composicion farmaceutica que contiene oxcarbazepina con liberacion controlada de la substancia activa.
|
CA2494660A1
(en)
*
|
2002-08-06 |
2004-02-19 |
Novartis Ag |
Use of carboxamides for the treatment of tinnitus
|
GB0221956D0
(en)
*
|
2002-09-20 |
2002-10-30 |
Novartis Ag |
Organic compounds
|
EP1663247B1
(en)
*
|
2003-09-03 |
2009-10-28 |
Novartis AG |
Use of oxcarbazepine for the improvement of sleep in patients suffering from chronic pain
|
PE20060124A1
(es)
*
|
2004-03-22 |
2006-03-07 |
Novartis Ag |
Tabletas de desintegracion que comprenden licarbazepina
|
WO2006046105A1
(en)
*
|
2004-10-25 |
2006-05-04 |
Ranbaxy Laboratories Limited |
Oxcarbazepine dosage forms
|
US20060252745A1
(en)
|
2005-05-06 |
2006-11-09 |
Almeida Jose L D |
Methods of preparing pharmaceutical compositions comprising eslicarbazepine acetate and methods of use
|
WO2007008576A2
(en)
*
|
2005-07-08 |
2007-01-18 |
Taro Pharmaceuticals U.S.A., Inc. |
Oxcarbazepine formulation
|
WO2007029093A2
(en)
*
|
2005-09-05 |
2007-03-15 |
Ranbaxy Laboratories Limited |
Pharmaceutical dosage forms of oxcarbazepine
|
EP1815849A1
(en)
*
|
2006-01-31 |
2007-08-08 |
Teva Pharmaceutical Industries Ltd |
Oxcarbazepine pharmaceutical formulation and its method of preparation, wherein oxcarbazepine has a broad and multi-modal particle size distribution
|
JP2008540346A
(ja)
*
|
2006-01-31 |
2008-11-20 |
テバ ファーマシューティカル インダストリーズ リミティド |
オキシカルバゼピンの医薬製剤及びその調製方法
|
EP2359830B1
(en)
|
2006-04-26 |
2012-09-19 |
Supernus Pharmaceuticals, Inc. |
Controlled released preparations of oxcarbazepine having sigmoidal release profile
|
US20080138403A1
(en)
*
|
2006-12-08 |
2008-06-12 |
Sun Pharmaceutical Industries Ltd. |
Pharmaceutical dosage forms of oxcarbazepine
|
GB0700773D0
(en)
|
2007-01-15 |
2007-02-21 |
Portela & Ca Sa |
Drug therapies
|
ES2559838T3
(es)
|
2007-03-16 |
2016-02-16 |
Concert Pharmaceuticals, Inc. |
Inhibidores de proteína de transferencia de ésteres de colesterol
|
US8198305B2
(en)
*
|
2007-04-13 |
2012-06-12 |
Concert Pharmaceuticals Inc. |
1,2-benzisoxazol-3-yl compounds
|
WO2008131259A1
(en)
*
|
2007-04-19 |
2008-10-30 |
Concert Pharmaceuticals Inc. |
Deuterated morpholinyl compounds
|
EP2527336A1
(en)
|
2007-04-25 |
2012-11-28 |
Concert Pharmaceuticals Inc. |
Deuterated analogues of cilostazol
|
CN101687868B
(zh)
*
|
2007-05-01 |
2012-12-12 |
康塞特医药品公司 |
吗啡烷化合物
|
FI3825306T3
(fi)
|
2007-05-01 |
2023-08-23 |
Concert Pharmaceuticals Inc |
Morfinaaniyhdisteitä
|
EP3632916B1
(en)
|
2007-05-01 |
2022-06-08 |
Concert Pharmaceuticals Inc. |
Morphinan compounds
|
EP2150525A1
(en)
|
2007-05-01 |
2010-02-10 |
Concert Pharmaceuticals Inc. |
Naphthyl(ethyl) acetamides
|
DE602008000255D1
(de)
|
2007-06-12 |
2009-12-17 |
Concert Pharmaceuticals Inc |
Azapeptid-Derivate als HIV-Protease-Inhibitoren
|
EP2212298B1
(en)
*
|
2007-10-18 |
2013-03-27 |
Concert Pharmaceuticals Inc. |
Deuterated etravirine
|
EP2265334A2
(en)
|
2008-02-29 |
2010-12-29 |
Concert Pharmaceuticals, Inc. |
Substituted xanthine derivatives
|
US20110160253A1
(en)
*
|
2008-05-28 |
2011-06-30 |
Harbeson Scott L |
Deuterated tizanidine
|
WO2010019557A1
(en)
*
|
2008-08-12 |
2010-02-18 |
Concert Pharmaceuticals Inc. |
N-phenyl-2-pyrimidineamine derivatives
|
BRPI0918760A2
(pt)
|
2008-09-19 |
2015-12-29 |
Concert Pharmaceuticals Inc |
compostos morfinanos
|
EP2364151A1
(en)
|
2008-10-30 |
2011-09-14 |
Concert Pharmaceuticals Inc. |
Combination of morphinan compounds and antidepressant for the treatment of pseudobulbar affect, neurological diseases, intractable and chronic pain and brain injury
|
EP3090760A1
(en)
|
2008-10-30 |
2016-11-09 |
Concert Pharmaceuticals, Inc. |
Combination of morphinan compounds and antidepressant for the treatment of pseudobulbar affect, neurological diseases, intractable and chronic pain and brain injury
|
CN102202678A
(zh)
|
2008-11-04 |
2011-09-28 |
安科治疗公司 |
Cxcr4受体化合物
|
WO2010065755A1
(en)
|
2008-12-04 |
2010-06-10 |
Concert Pharmaceuticals, Inc. |
Deuterated pyridinones
|
US20110053961A1
(en)
|
2009-02-27 |
2011-03-03 |
Concert Pharmaceuticals, Inc. |
Substituted xanthine derivatives
|
US8563554B2
(en)
|
2009-03-17 |
2013-10-22 |
Concert Pharmaceuticals, Inc. |
Deuterated pyrazinoisoquinoline compounds
|
US20120244122A1
(en)
|
2009-05-28 |
2012-09-27 |
Masse Craig E |
Peptides for the Treatment of HCV Infections
|
US8501738B2
(en)
|
2009-06-23 |
2013-08-06 |
Concert Pharmaceuticals, Inc. |
Substituted triazolo-pyridazine derivatives
|
US20110015154A1
(en)
*
|
2009-07-20 |
2011-01-20 |
Kellermann Gottfried H |
Supporting acetylcholine function
|
US8278460B2
(en)
|
2009-10-15 |
2012-10-02 |
Concert Pharmaceuticals, Inc. |
Substituted benzimidazoles
|
US20110098265A1
(en)
*
|
2009-10-28 |
2011-04-28 |
Neuroscience, Inc. |
Methods for reducing cravings and impulses associated with addictive and compulsive behaviors
|
WO2011060216A1
(en)
|
2009-11-12 |
2011-05-19 |
Concert Pharmaceuticals Inc. |
Substituted azaindoles
|
EP2536696A1
(en)
|
2010-02-18 |
2012-12-26 |
Concert Pharmaceuticals Inc. |
Pyrimidine derivatives
|
WO2011106703A2
(en)
|
2010-02-26 |
2011-09-01 |
Anchor Therapeutics, Inc. |
Cxcr4 receptor compounds
|
WO2011109464A1
(en)
|
2010-03-02 |
2011-09-09 |
Concert Pharmaceuticals Inc. |
Deuterated tetrahydronaphthalene derivatives
|
US8575361B2
(en)
|
2010-03-02 |
2013-11-05 |
Concert Pharmaceuticals Inc. |
Tetrahydronaphthalene derivatives
|
WO2012037060A1
(en)
|
2010-09-13 |
2012-03-22 |
Concert Pharmaceuticals Inc. |
Substituted azaindoles
|
WO2012065028A2
(en)
|
2010-11-11 |
2012-05-18 |
Concert Pharmaceuticals Inc. |
Substituted tetracyclines
|
WO2012079075A1
(en)
|
2010-12-10 |
2012-06-14 |
Concert Pharmaceuticals, Inc. |
Deuterated phthalimide derivatives
|
US8447329B2
(en)
|
2011-02-08 |
2013-05-21 |
Longsand Limited |
Method for spatially-accurate location of a device using audio-visual information
|
CA2828251A1
(en)
|
2011-02-25 |
2012-08-30 |
Concert Pharmaceuticals, Inc. |
2-amino-naphthyridine derivatives
|
WO2012129381A1
(en)
|
2011-03-22 |
2012-09-27 |
Concert Pharmaceuticals Inc. |
Deuterated preladenant
|
US20140213553A1
(en)
|
2011-05-03 |
2014-07-31 |
Concert Pharmaceuticals Inc. |
Carbamoylpyridone derivatives
|
US20140128469A1
(en)
|
2011-05-10 |
2014-05-08 |
Concert Pharmaceuticals Inc. |
Deuterated n-butyl bumetanide
|
PL3235812T3
(pl)
|
2011-05-18 |
2020-04-30 |
Vertex Pharmaceuticals (Europe) Limited |
Deuterowane pochodne iwakaftoru
|
WO2013013052A1
(en)
|
2011-07-19 |
2013-01-24 |
Concert Pharmaceuticals, Inc. |
Substituted xanthine derivatives
|
CA2860740A1
(en)
|
2012-01-09 |
2013-07-18 |
Anchor Therapeutics, Inc. |
Apj receptor compounds
|
WO2013130849A1
(en)
|
2012-02-29 |
2013-09-06 |
Concert Pharmaceuticals, Inc. |
Substituted dioxopiperidinyl phthalimide derivatives
|
IN2014DN08443A
(no)
|
2012-04-13 |
2015-05-08 |
Concert Pharmaceuticals Inc |
|
WO2013159026A1
(en)
|
2012-04-20 |
2013-10-24 |
Concert Pharmaceuticals, Inc. |
Deuterated rigosertib
|
EP3450434B1
(en)
|
2012-06-15 |
2021-02-24 |
CoNCERT Pharmaceuticals, Inc. |
Deuterated derivatives of ruxolitinib
|
EP2885267B1
(en)
|
2012-07-12 |
2018-09-05 |
Concert Pharmaceuticals, Inc. |
Deuterated idebenone
|
EA031716B1
(ru)
|
2012-08-17 |
2019-02-28 |
Консерт Фармасьютикалс, Инк. |
Дейтерированный барицитиниб
|
WO2014078842A1
(en)
|
2012-11-19 |
2014-05-22 |
Concert Pharmaceuticals, Inc. |
Deuterated cftr potentiators
|
US20150299166A1
(en)
|
2012-12-20 |
2015-10-22 |
Concert Pharmaceuticals, Inc. |
Deuterated alk inhibitors
|
WO2014100733A1
(en)
|
2012-12-21 |
2014-06-26 |
Mayo Foundation For Medical Education And Research |
Methods and materials for treating calcific aortic valve stenosis
|
WO2014110322A2
(en)
|
2013-01-11 |
2014-07-17 |
Concert Pharmaceuticals, Inc. |
Substituted dioxopiperidinyl phthalimide derivatives
|
JP2016512831A
(ja)
|
2013-03-15 |
2016-05-09 |
コンサート ファーマシューティカルズ インコーポレイテッド |
重水素化されたパルボシクリブ
|
CA2906396A1
(en)
|
2013-03-15 |
2014-09-25 |
Concert Pharmaceuticals Inc. |
Inhibitors of the enzyme udp-glucose: n-acyl-sphingosine glucosyltransferase
|
HU231191B1
(hu)
|
2013-04-15 |
2021-08-30 |
Szegedi Tudományegyetem |
Izotóp tartalmú morfin molekulák
|
US20160159861A1
(en)
|
2013-07-18 |
2016-06-09 |
Anchor Therapeutics, Inc. |
APJ Receptor Compounds
|
WO2015009889A1
(en)
|
2013-07-18 |
2015-01-22 |
Concert Pharmaceuticals, Inc. |
Deuterated intedanib derivatives and their use for the treatment of proliferative disorders
|
WO2015031741A1
(en)
|
2013-08-30 |
2015-03-05 |
Concert Pharmaceuticals, Inc. |
Deuterated derivatives of a thienotriazolodiazapine bromodomain-containing protein inhibitor
|
WO2015063670A1
(en)
*
|
2013-10-30 |
2015-05-07 |
Wockhardt Limited |
Solid oral modified-release composition comprising oxcarbazepine or a pharmaceutically acceptable salt thereof
|
JP6526060B2
(ja)
|
2014-02-10 |
2019-06-05 |
コンサート ファーマシューティカルズ インコーポレイテッド |
置換トリアゾロベンゾジアゼピン
|
CN106456647A
(zh)
|
2014-04-18 |
2017-02-22 |
康塞特医药品有限公司 |
治疗高血糖症的方法
|
WO2015179772A1
(en)
|
2014-05-23 |
2015-11-26 |
Concert Pharmaceuticals, Inc. |
Deuterated phenylquinazolinone and phenylisoquinolinone compounds
|
AU2015269247B2
(en)
|
2014-06-06 |
2019-10-24 |
Research Triangle Institute |
Apelin receptor (APJ) agonists and uses thereof
|
EP3177292B1
(en)
|
2014-08-07 |
2020-11-25 |
Mayo Foundation for Medical Education and Research |
Compounds and methods for treating cancer
|
WO2016061488A1
(en)
|
2014-10-17 |
2016-04-21 |
Concert Pharmaceuticals, Inc. |
Amine reuptake inhibitors
|
WO2016073545A1
(en)
|
2014-11-06 |
2016-05-12 |
Concert Pharmaceuticals, Inc. |
Phenyloxadiazole benzoic acids
|
WO2016089814A1
(en)
|
2014-12-02 |
2016-06-09 |
Concert Pharmaceuticals, Inc. |
Deuterated analogues of daclatasvir
|
WO2016105547A1
(en)
|
2014-12-24 |
2016-06-30 |
Concert Pharmaceuticals, Inc. |
Deuterated dasabuvir
|
WO2016109795A1
(en)
|
2014-12-31 |
2016-07-07 |
Concert Pharmaceuticals, Inc. |
Deuterated funapide and difluorofunapide
|
WO2016144830A1
(en)
|
2015-03-06 |
2016-09-15 |
Concert Pharmaceuticals, Inc. |
Deuterated emricasan
|
WO2016160945A1
(en)
|
2015-03-31 |
2016-10-06 |
Concert Pharmaceuticals, Inc. |
Deuterated vx-661
|
US10683305B2
(en)
|
2015-04-27 |
2020-06-16 |
Concert Pharmaceuticals, Inc. |
Deuterated OTX-015
|
WO2017020005A1
(en)
|
2015-07-30 |
2017-02-02 |
Concert Pharmaceuticals, Inc. |
Morphinan compounds for use in treating agitation
|
WO2017020002A1
(en)
|
2015-07-30 |
2017-02-02 |
Concert Pharmaceuticals, Inc. |
Deuterated morphinan compounds for use in treating agitation
|
BR112018005454A2
(pt)
|
2015-09-21 |
2018-10-09 |
Vertex Pharmaceuticals Europe Ltd |
administração de potencializadores de cftr deuterados
|
WO2017087795A1
(en)
|
2015-11-19 |
2017-05-26 |
Concert Pharmaceuticals, Inc. |
Deuterated epi-743
|
US10100059B2
(en)
|
2015-12-09 |
2018-10-16 |
Research Triangle Institute |
Apelin receptor (APJ) agonists and uses thereof
|
WO2017147003A1
(en)
|
2016-02-26 |
2017-08-31 |
Novobiotic Pharmaceuticals, Llc |
Novel macrocyclic antibiotics and uses thereof
|
BR112018072339A2
(pt)
|
2016-05-04 |
2019-02-19 |
Concert Pharmaceuticals, Inc. |
tratamento de distúrbios de perda de cabelo com inibidores de jak deuterados
|
US10730841B2
(en)
|
2016-07-04 |
2020-08-04 |
Avanir Pharmaceuticals, Inc. |
Methods for the synthesis of deuterated dextromethorphan
|
JP7178341B2
(ja)
|
2016-08-01 |
2022-11-25 |
ザ ブリガム アンド ウィメンズ ホスピタル インコーポレイテッド |
タンパク質およびペプチドの送達のための粒子
|
WO2018160717A1
(en)
|
2017-02-28 |
2018-09-07 |
Mayo Foundation For Medical Education And Research |
Compounds and methods for treating cancer
|
US11278025B2
(en)
|
2017-05-17 |
2022-03-22 |
The General Hospital Corporation |
Antibiotic compounds
|
BR112019024177A2
(pt)
|
2017-05-19 |
2020-06-02 |
Superb Wisdom Limited |
Derivados de resiquimode
|
WO2019104179A1
(en)
|
2017-11-22 |
2019-05-31 |
Concert Pharmaceuticals, Inc. |
Deuterated analogs of d-serine and uses thereof
|
US11243207B2
(en)
|
2018-03-29 |
2022-02-08 |
Mayo Foundation For Medical Education And Research |
Assessing and treating cancer
|
WO2021236139A1
(en)
|
2020-05-21 |
2021-11-25 |
Concert Pharmaceuticals, Inc. |
Novel deuterated jak inhibitor and uses thereof
|
AU2021372512A1
(en)
|
2020-10-28 |
2023-06-22 |
Sun Pharmaceutical Industries, Inc. |
Regimens for the treatment of hair loss disorders with deuterated jak inhibitors
|
AU2022328272A1
(en)
|
2021-08-11 |
2024-02-22 |
Sun Pharmaceutical Industries, Inc. |
Treatment of hair loss disorders with deuterated jak inhibitors
|
AU2022328282A1
(en)
|
2021-08-12 |
2024-02-22 |
Sun Pharmaceutical Industries, Inc. |
Treatment of jak-inhibition-responsive disorders with prodrugs of jak inhibitors
|
WO2023215520A1
(en)
|
2022-05-04 |
2023-11-09 |
Sun Pharmaceutical Industries, Inc. |
Dosage regimens for treatment with deuterated jak inhibitors
|